Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Michiko, Nonaka"'
Autor:
Michiko Nonaka, Seiya Sato, Daiken Osaku, Mayumi Sawada, Akiko Kudoh, Jun Chikumi, Shinya Sato, Tetsuro Oishi, Tasuku Harada
Publikováno v:
Gynecologic Oncology Reports, Vol 26, Iss , Pp 21-23 (2018)
Bevacizumab (Bev) is an antiangiogenic drug used to treat various malignances, including ovarian cancer (OC). Bev is generally well-tolerated; however, it has a characteristic toxicity profile. In particular, gastrointestinal perforation (GIP) is a r
Externí odkaz:
https://doaj.org/article/6f41bc7b795b420d95b66287694e4c12
Autor:
Mayumi Sawada, Tetsuro Oishi, Michiko Nonaka, Kohei Hikino, Masayo Ookawa, Yuki Iida, Masayo Hosokawa, Hiroaki Komatsu, Akiko Kudoh, Shinya Sato, Fuminori Taniguchi
Publikováno v:
Yonago Acta Medica; 2023, Vol. 66 Issue 4, p459-462, 4p
Autor:
Shinsuke ODA, Satoshi KUWAMOTO, Michiko MATSUSHITA, Yusuke TOKUYASU, Michiko NONAKA, Shu NAKAMOTO
Publikováno v:
The Journal of the Japanese Society of Clinical Cytology. 61:48-52
Autor:
Shinya Sato, Mayumi Sawada, Tasuku Harada, Akiko Kudoh, Daiken Osaku, Tetsuro Oishi, Jun Chikumi, Seiya Sato, Michiko Nonaka
Publikováno v:
Gynecologic Oncology Reports, Vol 26, Iss, Pp 21-23 (2018)
Gynecologic Oncology Reports
Gynecologic Oncology Reports
Bevacizumab (Bev) is an antiangiogenic drug used to treat various malignances, including ovarian cancer (OC). Bev is generally well-tolerated; however, it has a characteristic toxicity profile. In particular, gastrointestinal perforation (GIP) is a r
Autor:
Takashi Ushiwaka, Mitsutake Yano, Hirokuni Takano, Takaya Shiozaki, Kazuto Tasaki, Masamitsu Kurakazu, Ayumi Shikama, Taisuke Mori, Kimihiko Ito, Michiko Nonaka, Atsushi Arakawa, Kentaro Kai, Yasushi Iida, Kaei Nasu, Takashi Motohashi, Hideki Tokunaga, Hiroyuki Morisawa, Etsuko Fujimoto, Satoshi Nakagawa, Yuko Imamura, Yuki Yamada, Takashi Yamada, Haruto Nishida, Norihiro Teramoto, Tomohiko Tsuruta, Tsutomu Daa, Harunobu Matsumoto
Publikováno v:
Neuroendocrinology. 111(4)
Background: In 2014, the World Health Organization (WHO) released a classification system introducing neuroendocrine neoplasms (NENs) of the female reproductive tract, excluding the ovaries. This study aimed to evaluate whether retrospective adaption
Autor:
Michiko Nonaka, Mayumi Sawada, Shinya Sato, Hiroaki Itamochi, Daiken Osaku, Hiroaki Komatsu, Tetsuro Oishi, Seiya Sato, Akiko Kudoh, Tasuku Harada, Muneaki Shimada
Publikováno v:
Anticancer research. 39(8)
Background/aim Treatments for controlling delayed nausea after chemotherapy are inadequate, potentially inciting malnutrition. We sought to determine the incidence of nausea, anorexia, and food intake after chemotherapy. Patients and methods Subjects
Autor:
Tasuku Harada, Tetsuro Oishi, Jun Chikumi, Hiroaki Itamochi, Muneaki Shimada, Toru Sugiyama, Youhei Chiba, Akiko Kudoh, Seiya Sato, Nao Oumi, Hiroaki Komatsu, Michiko Nonaka, Shinya Sato
Publikováno v:
Human Cell. 29:181-187
A new cell line of human ovarian clear cell carcinoma (CCC), TU-OC-2, was established and characterized. The cells were polygonal in shape, grew in monolayers without contact inhibition and were arranged in islands like pieces of a jigsaw puzzle. The
Autor:
Hiroaki Komatsu, Tasuku Harada, Mayumi Sawada, Shinya Sato, Michiko Nonaka, Akiko Kudoh, Daiken Osaku, Jun Chikumi, Tetsuro Oishi
Publikováno v:
International journal of clinical oncology. 24(12)
There are few studies on serum vascular endothelial growth factors and receptors (VEGF/VEGFRs) in patients with uterine cervical cancer (CC). The aim of this study was to determine whether VEGF/VEGFRs could be used as prognostic biomarkers in patient
Autor:
Mayumi Sawada, Tasuku Harada, Hiroaki Komatsu, Michiko Nonaka, Jun Chikumi, Tetsuro Oishi, Shinya Sato, Daiken Osaku, Akiko Kudoh
Publikováno v:
Acta cytologica. 62(5-6)
Objectives: The aim of this study was to evaluate the diagnostic significance of high-risk human papillomavirus (hrHPV) testing for managing women with atypical glandular cells (AGC) and to explore the distribution of hrHPV genotypes. Methods: We ana
Autor:
Tetsuro Oishi, Hiroaki Komatsu, Makoto Wakahara, Jun Chikumi, Hiroaki Itamochi, Mayumi Sawada, Shinya Sato, Yoshihisa Umekita, Muneaki Shimada, Seiya Sato, Tasuku Harada, Michiko Nonaka
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 27(7)
BackgroundBevacizumab, which targets vascular endothelial growth factor (VEGF)-A, has recently been proven to be effective for the treatment of epithelial ovarian cancer (EOC). Thus, interest in VEGF-A has increased. There are few reports on concomit